News

Fangli Geng, Ph.D. candidate at CHDS, collaborated with researchers from the Chinese Academy of Medical Sciences & Peking Union Medical College to develop

COVID-19 vaccination is substantially more cost-effective than lockdowns, according to research conducted by CHDS faculty affiliate Joseph Pliskin and Ronen Arbel. Early in the COVID-19

CHDS faculty Ankur Pandya received the 2022 Roger L. Nichols Award for Excellence in Teaching at the Harvard Chan School’s Commencement Ceremony. The award is selected through a review of

CHDS faculty Ankur Pandya outlined how economic evaluation methods could be used to improve the process of making difficult policy choices around COVID-19 in a recently co-authored 

Steven Pearson spoke about the role of the Institute for Clinical and Economic Review (ICER) in encouraging the consideration of cost-effectiveness in US drug policy in a recent CHDS seminar.

The EPIC team at CHDS, led by CHDS faculty Stephen Resch, performed a systematic review of literature to describe research on the costs and cost-effectiveness of integrating

A recent study by CHDS Research Scientist Shafika Abrahams-Gessel and faculty Thomas A. Gaziano showed that federal food service guidelines improve health outcomes and are cost-saving. Despite

Jinyi Zhu, 6th year doctoral student in Decision Science/Health Policy, successfully defended her thesis, “Decision Modeling to Inform Resource Prioritization: Methods and

Nathaniel Hendrix, CHDS faculty Stéphane Verguet, and colleagues performed a systematic review of cost-effectiveness analyses that assessed activities designed to strengthen health

Alicia Yamin spoke about her work on fostering meaningful citizen participation in health priority setting during a recent CHDS seminar. Yamin is a lecturer on Law and Senior Fellow on Global Health and